ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023
NameSharesValueWeighting ↓
B. Metzler seel. Sohn & Co. AG 39,494$1,821,8580.02%
NATIXIS 64,700$2,984,6110.02%
PRICE T ROWE ASSOCIATES INC /MD/ 3,614,992$166,7610.02%
DEUTSCHE BANK AG\ 887,731$40,951,0310.02%
TUDOR INVESTMENT CORP ET AL 36,919$1,703,0730.02%
Mirae Asset Global Investments Co., Ltd. 192,123$8,865,5100.02%
Aquatic Capital Management LLC 7,500$3460.02%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 40,822$1,8830.02%
Gotham Asset Management, LLC 15,822$729,8690.02%
Candriam S.C.A. 49,480$2,282,5120.02%
Russell Investments Group, Ltd. 170,137$7,848,4170.02%
WCM INVESTMENT MANAGEMENT, LLC 105,305$4,867,1970.02%
PRELUDE CAPITAL MANAGEMENT, LLC 4,788$220,8700.01%
China Universal Asset Management Co., Ltd. 928$430.01%
Capital International Investors 967,357$44,624,1780.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 107,600$4,963,5880.01%
Column Capital Advisors, LLC 1,704$78,6060.01%
MACQUARIE GROUP LTD 215,668$9,949,0000.01%
CREDIT SUISSE AG/ 208,687$9,626,7310.01%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,494$68,9180.01%
External links

This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.